Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Phys Rev Lett ; 130(8): 089901, 2023 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-36898127

RESUMO

This corrects the article DOI: 10.1103/PhysRevLett.129.180402.

2.
BMC Pediatr ; 18(1): 322, 2018 10 11.
Artigo em Inglês | MEDLINE | ID: mdl-30309338

RESUMO

BACKGROUND: Childhood obesity continues to be a significant public health issue worldwide. Recent national studies in Spain show a stable picture. However, prevalence and trends differ by socio-economic status, age, and region. We present the trend in childhood excess weight prevalence, aged 8-15 years, in Andalusia from 2011-2012 to 2015-2016 by socio-economic status. METHODS: Using the cross-sectional Andalusian Health Surveys, objective anthropometric measures were taken for a representative sample of 8-15 year olds in Andalusia in 2011-2012 and 2015-2016. Prevalence and changes in prevalence of excess weight (overweight plus obesity) were calculated, using both the WHO and IOTF criteria, overall and for sex, age and three different indicators of SES. RESULTS: Overall prevalence of excess weight decreased from 42.0% in 2011-2012 to 35.4% in 2015-2016. Overweight decreased from 28.2 to 24.2% and obesity from 13.8 to 11.2%. In 2011-2012 the prevalence of excess weight in boys was 46.0%and 37.9% in girls; in 2015-2016 the difference became significant with 41% of boys with excess weight compared with 30% in girls. CONCLUSIONS: Childhood excess weight prevalence in Andalusia has decreased slightly between 2011-2012 and 2015-2016. Notably, a decrease in obesity prevalence in girls aged 8-15 years was recorded. In 2011-2012 a social gradient for excess weight prevalence across three SES indicators was observed: in 2015-2016 this gradient disappeared. Nonetheless, prevalence remains too high.


Assuntos
Obesidade Infantil/epidemiologia , Classe Social , Adolescente , Distribuição por Idade , Antropometria , Criança , Estudos Transversais , Feminino , Humanos , Masculino , Sobrepeso/epidemiologia , Prevalência , Distribuição por Sexo , Espanha/epidemiologia
3.
Cir. mayor ambul ; 12(2): 71-74, abr.-jun. 2007. ilus, tab
Artigo em Es | IBECS | ID: ibc-056771

RESUMO

Objetivos: Evaluar en una unidad de cirugía ambulatoria los indicadores de calidad básicos en relación con periodos anteriores de la misma unidad, y con los de otras unidades de cirugía ambulatoria. Material y métodos: Estudio prospectivo de los pacientes intervenidos en régimen ambulatorio en el periodo del 1 de enero de 2005 al 31 de diciembre de 2005. Se recogen para ello el número y tipo de complicaciones y los indicadores de calidad básicos de este tipo de cirugía (índice de suspensión, índice de ingresos e índice de sustitución). Resultados: Las complicaciones registradas en el periodo señalado fueron un total de 49 (0,98%) en los 4.966 procedimientos realizados en régimen de cirugía sin ingreso. De ellas, el 65,3% (32 casos) fueron complicaciones menores, frente a un 34,7% de complicaciones mayores. La complicación más frecuente fue la hemorragia del campo quirúrgico, siguiendo en importancia el dolor de herida quirúrgica y con menor incidencia los problemas infecciosos. El índice de sustitución fue de un 58,2%, el de suspensión del 6,95%, y el de ingresos de un 4,03%. Conclusiones: En nuestro estudio hemos podido observar una mejoría progresiva de los indicadores de la unidad de cirugía ambulatoria. Sin embargo, todavía es necesario continuar avanzando para ofrecer condiciones óptimas a los pacientes para la resolución de sus patologías, haciendo especial hincapié en una selección eficaz por parte de cirujano y anestesiólogo, y una evaluación preoperatoria cuidadosa (AU)


Objectives: To evaluate the unit of ambulatory surgery. To analyze and compare the basics quality indicators with previous periods of the same unit and with other centres. Material and methods: Study of the patients operated on program of ambulatory mayor surgery in the period of January, 1st 2005 to December, 31st 2005. In order to accomplish this goal, information is collected such as number and type of complications appeared, major and minor complications, and the basics quality indicators of this type of surgery (suspension index, admission index and substitution index). Results: The complications registered in that period were 49 from 4,966 in all carried procedures (0.98%). From these complications 32 cases, 65.3%, were minor complications, while 34.7% were mayor complications. The complication more frequent is the haemorrhage with 19 cases registered, next in importance is the surgery injure pain and with less incidence infectious problems. The substitution index was 58, 2% in 2005, the suspension index was 6.95% and the admission index was 4.03%. Conclusions: In our study we have noticed a progressive improvement of the indicators of the ambulatory surgery unit. However, it is still necessary to keep advancing in order to offer our patients the optimum conditions for the resolution of their pathologies insisting on an efficient selection by the surgeon and anaesthetist, and a careful presurgery evaluation (AU)


Assuntos
Humanos , Avaliação de Processos e Resultados em Cuidados de Saúde , Procedimentos Cirúrgicos Ambulatórios/normas , Qualidade da Assistência à Saúde , Complicações Pós-Operatórias , Hospitais Públicos , Hospitais com 100 a 299 Leitos , Estudos Prospectivos , Espanha
5.
Todo hosp ; (213): 20-27, ene.-feb. 2005.
Artigo em Espanhol | IBECS | ID: ibc-75660

RESUMO

El objetivo de este trabajo es el de crear unas ases para que cada centro sanitario pueda desarrollar protocolos de limpieza propios para áreas críticas (AU)


The objective of thiswork is to create bases so that each health cenre can develop cleaning protocols for critical areas (AU)


Assuntos
Humanos , Zeladoria Hospitalar/normas , Infecção Hospitalar/prevenção & controle , Detergentes/normas , Saneantes , Controle de Infecções/normas , Salas Cirúrgicas/normas
6.
Rev Neurol ; 36(8): 724-6, 2003.
Artigo em Espanhol | MEDLINE | ID: mdl-12717649

RESUMO

INTRODUCTION: Selective serotonin reuptake inhibitors (SSRIs) are often used as antidepressants in pregnant women. SSRIs do not appear to increase the teratogenic risk when used in their recommended doses. However, not enough information is available at this time about the risk of toxicity and complications in newborns, after mother treatment with SSRI during the third trimester of pregnancy. We are limited to the existing reports that describe newborns with symptoms due to hyperserotoninemia or withdrawal. CASE REPORT: One newborn whose mother had been treated with paroxetine 20 mg/day during pregnancy, presented convulsions and subarachnoid haemorrhage in the first six hours of life. The newborn did not present symptoms of hypoxic ischaemic encephalopathy, withdrawal syndrome, infection, metabolic alterations, cerebral malformations or coagulopaties. DISCUSSION: The most probable etiology is that the paroxetine could decrease the seizure threshold, taking place the first seizure during delivery. The difficult fetal extraction would have provoked the subarachnoid haemorrhage in a patient with an impaired haemostatic function due to a depletion of platelet serotonin and may also contribute the increased vascular fragility due to paroxetine and reported in adults or in animals. CONCLUSION: Neonatal convulsions and subarachnoid haemorrhage may occur after paroxetine treatment in the third trimester of pregnancy. An accurate follow up of these newborns in the firsts days of life is strongly recommended.


Assuntos
Paroxetina/efeitos adversos , Convulsões/induzido quimicamente , Inibidores Seletivos de Recaptação de Serotonina/efeitos adversos , Hemorragia Subaracnóidea/induzido quimicamente , Adulto , Feminino , Humanos , Recém-Nascido , Gravidez , Terceiro Trimestre da Gravidez
7.
Rev. neurol. (Ed. impr.) ; 36(8): 724-726, 16 abr., 2003.
Artigo em Es | IBECS | ID: ibc-27576

RESUMO

Introducción. Los inhibidores selectivos de la recaptación de serotonina (ISRS) se emplean con frecuencia como antidepresivos en las mujeres embarazadas. Cuando se administran con la posología recomendada los ISRS no parecen aumentar el riesgo teratógeno. Sin embargo, actualmente no se dispone de suficiente información sobre el riesgo de producirse toxicidad y complicaciones en los neonatos después de tratarse la madre con ISRS durante el tercer trimestre de gestación. Sólo disponemos de los casos publicados donde se describen a neonatos con síntomas provocados por una hiperserotoninemia o por privación. Caso clínico. Un neonato, cuya madre se había tratado con 20 mg/día de paroxetina durante el embarazo, presenta convulsiones y una hemorragia subaracnoidea durante las seis primeras horas de vida. El neonato no presentaba síntomas de encefalopatía isquémica hipóxica, síndrome de abstinencia ,infección, trastornos metabólicos, malformaciones cerebrales ni coagulopatías. Discusión. La etiología más probable es que la paroxetina provoca una reducción del umbral convulsivo, las primeras convulsiones ocurriendo durante el parto. La difícil extracción del feto habría provocado una hemorragia subaracnoidea en un paciente con una disfunción hemostática causada por una disminución de la serotonina de los trombocitos y también puede contribuir al incremento de la fragilidad vascular ocasionada por la paroxetina que se ha descrito en los adultos o los animales. Conclusión. Las convulsiones y la hemorragia subaracnoidea pueden presentarse en los neonatos después de tratarse la madre con paroxetina durante el tercer trimestre del embarazo. Es muy aconsejable realizar un seguimiento exhaustivo de estos neonatos durante los primeros días de vida (AU)


Introduction. Selective serotonin reuptake inhibitors (SSRIs) are often used as antidepressants in pregnant women. SSRIs do not appear to increase the teratogenic risk when used in their recommended doses. However, not enough information is available at this time about the risk of toxicity and complications in newborns, after mother treatment with SSRI during the third trimester of pregnancy. We are limited to the existing reports that describe newborns with symptoms due to hyperserotoninemia or withdrawal.Case report. One newborn whose mother had been treated with paroxetine 20 mg/day during pregnancy, presented convulsions and subarachnoid haemorrhage in the first six hours of life. The newborn did not present symptoms of hypoxic ischaemic encephalopathy, withdrawal syndrome, infection, metabolic alterations, cerebral malformations or coagulopaties. Discussion.The most probable etiology is that the paroxetine could decrease the seizure threshold, taking place the first seizure during delivery. The difficult fetal extraction would have provoked the subarachnoid haemorrhage in a patient with an impaired haemostatic function due to a depletion of platelet serotonin and may also contribute the increased vascular fragility due to paroxetine and reported in adults or in animals. Conclusion. Neonatal convulsions and subarachnoid haemorrhage may occur after paroxetine treatment in the third trimester of pregnancy. An accurate follow-up of these newborns in the firsts days of life is strongly recommended (AU)


Assuntos
Gravidez , Adulto , Recém-Nascido , Feminino , Humanos , Hemorragia Subaracnóidea , Inibidores Seletivos de Recaptação de Serotonina , Paroxetina , Terceiro Trimestre da Gravidez , Convulsões
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...